Efficacy of a liver resection for hepatocellular carcinoma in patients with chronic renal failure

Surgery Today

Volumn 38, Issue 4, 2008, Pages 329-334

  Orii, Takashi ^a,b   Takayama, Tetsuro ^a   Haga, Izumi ^a   Fukumori, Tatsuya ^a   Amada, Noritoshi ^a  

^a Japan Community Healthcare Organization Sendai Hospital   (Japan)

^b Department of Surgery   (Japan)

Author keywords

Chronic renal failure; Hepatectomy; Hepatocellular carcinoma

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LUNG INSUFFICIENCY; MALE; SURVIVAL RATE;

CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; JAPAN; KIDNEY FAILURE, CHRONIC; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 43349090568     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-007-3634-1     Document Type: Article

References (28)

1. Moran JE, Prosl F. Totally implantable subcutaneous devices for hemodialysis access. Contrib Nephrol 2004;142:178-192.
2. Santoro A, Canova C, Feyrie A, Mancini E. Vascular access for hemodialysis. J Nephrol 2006;19(3):259-264.
3. Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999;354(9173):93-99.
4. Cuckovic C, Djukanovic L, Jankovic S, Stanojcic A, Dragicevic P, Radmilovic A, et al. Malignant tumors in hemodialysis patient. Nephron 1996;73(4):710-712.
5. Locatelli F, Pozzoni P, Tentori F, Vecchio LD. Epidemiology of cardiovascular risk in patients with chronic kidney disease. Nephrol Dial Transplant 2003;18Suppl 7:2-9.
6. Sharma R, Pellerin D, Brecker SJ. Cardiovascular disease in end stage renal disease. Minerva Urol Nefrol 2006;58(2):117-131.
7. Varma R, Garrick R, McClung J, Frishman WH. Chronic renal dysfunction as an independent risk factor for the development of cardiovascular disease. Cardiol Rev 2005;13(2):98-107.
8. Guerin AP, Adda H, London GM, Marchais SJ. Cardiovascular disease in renal failure. Minerva Urol Nefrol 2004;56(3):279-288.
9. Chonchol M. Neutrophil dysfunction and infection risk in end-stage renal disease. Semin Dial 2006;19(4):291-296.
10. Cendoroglo M, Jaber BL, Balakrishnan VS, Perianayagam M, King AJ, Pereira BJ. Neutrophil apoptosis and dysfunction in urema. J Am Soc Nephrol 1999;10(1):90-100.
11. Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 2000;58(4):1758-1764.
12. Sarnak MJ, Jaber BL. Pulmonary infectious mortality among patients with end-stage renal disease. Chest 2001;120(6):1883-1887.
13. Kaw D, Malhotra D. Platelet dysfunction and end-stage renal disease. Semin Dial 2006;19(4):317-322.
14. Borlase B, Simon JS, Hermann G. Abdominal surgery in patients undergoing chronic hemodialysis. Surgery 1987;102(1):15-18.
15. Toh Y, Yano K, Takesue F, Korenaga D, Maekawa S, Muto Y, et al. Abdominal surgery for patients on maintenance hemodialysis. Surg Today 1998;28(3):268-272.
16. Wind P, Douard R, Rouzier R, Berger A, Bony C, Cugnenc PH. Abdominal surgery in chronic hemodialysis patients. Am Surg 1999;65(4):347-351.
17. Harada A, Nakao A, Nonami T, Kobayashi H, Maruyama H, Suenaga M, et al. Partial hepatectomy for hepatocellular carcinoma in 6 hemodialysis patients. Nihon Shokakigeka Gakkai Zasshi 1993;26(9):2347-2351.
18. Sasaki Y, Yamada T, Ohigashi H, Doki Y, Kameyama M, Hiratsuka M, et al. Surgery for hepatocellular carcinoma in hemodialysis patients. Rinsho Toseki 2002;18(6):661-666.
19. Yamagata M, Kanematsu T, Matsumata T, Nishizaki T, Utsunomiya T, Sugimachi K, et al. Possibility of hepatic resection in patients on maintenance hemodialysis. Hepatogastroenterology 1993;40(3):249-252.
20. Yeh CN, Lee WC, Chen MF. Hepatic resection for hepatocellular carcinoma in end-stage renal disease patients: two decades of experience at Chang Gung Memorial Hospital. World J Gastroenterol 2005;11(14):2067-2071.
21. Cheng SB, Wu CC, Shu KH, Ho WL, Chen JT, Yeh DC, et al. Liver resection for hepatocellular carcinoma in Patients with endstage renal failure. J Surg Oncol 2001;78(4):241-246.
22. Deenitchina SS, Ando T, Okuda S, Kinukawa N, Hirakata H, Nagashima A, et al. Cellular immunity in hemodialysis patients: a quantitative analysis of immune cell subsets by flow cytometry. Am J Nephrol 1995;15(1):57-65.
23. Kelly CJ. T cell function in chronic renal failure and dialysis. Blood Purif 1994;12(1):36-41.
24. Raska K Jr, Raskova J, Shea SM, Frankel RM, Wood RH, Lifter J, et al. T cell subsets and cellular immunity in end-stage renal disease. Am J Med 1983;75(5):734-740.
25. Roskova J, Ghobrial K, Czerwinski DK, Shea SM, Eisinger RP, Raska K Jr. B-cell activation and immunoregulation in end-stage renal disease patients receiving hemodialysis. Arch Intern Med 1987;147(1):89-93.
26. Nagasue N, Kohno H, Hayashi T, Uchida M, Ono T, Yukaya H, et al. Repeated hepatectomy for recurrent hepatocellular carcinoma. Br J Surg 1996;83(1):127-131.
27. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 1999;229(2):216-222.
28. Taura K, Ikai I, Hatano E, Fujii H, Uyama N, Shimahara Y. Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old. Ann Surg 2006;244(2):265-273.